¿Es c12-13 pareth-15 seguro durante el embarazo?
CIR’s safety assessment of alkyl PEG/alkyl PEG‑ether ingredients (which explicitly covers C12‑13 pareth variants including C12‑13 Pareth‑15) concluded these ingredients are safe “when formulated to be non‑irritating” and reported negative reproductive/developmental study findings. ECHA registration/read‑across dossiers for C12‑13 alcohol ethoxylates report no reproductive hazards in available animal studies. Dermal cosmetic use therefore shows no evidence of reproductive hazard, but low measurable dermal exposure is plausible. (CIR 2012; PubMed summary; ECHA registration dossier).
Related ingredients
Frequently asked questions
- ¿Es c12-13 pareth-15 seguro durante el embarazo?
- CIR’s safety assessment of alkyl PEG/alkyl PEG‑ether ingredients (which explicitly covers C12‑13 pareth variants including C12‑13 Pareth‑15) concluded these ingredients are safe “when formulated to be non‑irritating” and reported negative reproductive/developmental study findings. ECHA registration/read‑across dossiers for C12‑13 alcohol ethoxylates report no reproductive hazards in available animal studies. Dermal cosmetic use therefore shows no evidence of reproductive hazard, but low measurable dermal exposure is plausible. (CIR 2012; PubMed summary; ECHA registration dossier).
- ¿Es c12-13 pareth-15 seguro durante la lactancia?
- Same evidence base as pregnancy: no reproductive/developmental hazard identified in the CIR review and in ECHA dossiers. Dermal exposure from cosmetics is expected to be low but measurable; no data indicate mammary‑specific toxicity or contraindication for breastfeeding. (CIR 2012; ECHA dossier).
- ¿Es c12-13 pareth-15 seguro para la piel del bebé?
- No infant‑specific reproductive or developmental toxicity data were found. The parent class has no identified reproductive hazard. Because infant skin has higher permeability/surface‑area‑to‑weight, exposure score is increased by +1 versus adults (adult e=1 → infant e=2). Note: this increases exposure only; hazard and mechanism remain unsupported by evidence. CIR recommends formulation to be non‑irritating. (CIR 2012; ECHA registration/read‑across).
- ¿Cómo puntúa VeriMom a c12-13 pareth-15?
- VeriMom puntúa c12-13 pareth-15 en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a c12-13 pareth-15 en el embarazo?
- Consulta nuestra lista de alternativas seguras a c12-13 pareth-15 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.